A challenge in anticipating generic entry is elucidating which patents and regulatory protections constrain generic entry. Yali Friedman at DrugPatentWatch presents a set of an estimated loss of exclusivity dates for four drugs, from September through November 2021. These estimated drug patent expiration dates and generic entry opportunity dates are calculated from analysis of known patents and US regulatory protections covering drugs.
Current Edition
Current Features
Subsection - Neurodegenerative Diseases
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue reading
4 Drugs Facing Key Patent Expirations and Potential Generic Entry From September 2021–November 2021
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.
Bio Pharmaceutical Media © 2026, All Rights Reserved – Powered by Teksyte